Drug intelligence / Profile preview

daikenchuto

Development stage
Phase 2
Lead developer
Tsumura
Modality
Small Molecules
Administration
Oral
01

Overview

Daikenchuto (DKT) is a traditional Japanese Kampo medicine composed of four crude drugs in specific ratios: dried Japanese pepper (Zanthoxylum piperitum), processed ginger (Zingiberis Siccatum Rhizoma), ginseng radix (Panax ginseng), and maltose powder. It is used primarily to treat gastrointestinal disorders such as abdominal cold feeling, abdominal pain accompanied by flatulence, chronic constipation, irritable bowel syndrome, postoperative ileus, Crohn’s disease, adhesive ileus, and paralytic ileus. The drug promotes gastrointestinal motility and improves blood flow in the gastrointestinal tract. Its mechanisms include anti-inflammatory effects through selective inhibition of cyclooxygenase-2 (COX-2) and downregulation of inflammatory mediators like tumor necrosis factor-alpha and interleukin-1 beta. It also increases gastrointestinal blood flow via induction of calcitonin gene-related peptide (CGRP), substance P, and vasoactive intestinal polypeptide (VIP). Additionally, it modulates the colonic immune system by enhancing group 3 innate lymphoid cells which help maintain colonic microenvironment integrity. Daikenchuto has been approved for prescription use in Japan since 1986 and is under investigation in the US for constipation and Crohn’s disease.

Brand names
TSUMURA Daikenchuto Extract Granules
Other names
DaikenchutoDKT
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)SP (Substance P)CGRP (Calcitonin gene-related peptide)TNFA (Tumor necrosis factor alpha (soluble))IL1B (Interleukin-1 beta)

Beyond the preview

Go deeper on daikenchuto.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on daikenchuto.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call